Trial Profile
A Real-world study assessing the clinical and economic outcomes of daily teriparatide for the treatment of osteoporosis in Japanese patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2017
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Fracture; Osteoporosis
- Focus Therapeutic Use
- Acronyms GPORWE
- 31 Mar 2017 New trial record